Takeda Estimates Double Digit Sales Increase
This article was originally published in PharmAsia News
Takeda announced Oct. 20 revised estimated results for the first two fiscal quarters of the year. The company estimates group sales will grow by 13 percent to ¥805 billion from a previous ¥760 billion, business operating income will increase from ¥50 billion to ¥85 billion, and a current earnings increase from ¥50 billion to ¥70 billion. Takada will announce final results Nov. 4. (Click here for more - Japanese language
You may also be interested in...
The US Medicare agency on 7 April said it delivered $34bn to suppliers of durable medical equipment and other providers fighting COVID-19 via an accelerated payment program.
Class Action Watch: Plaintiffs Target L’Oreal’s Pump-Dispensed Liquid Cosmetics, GNC’s Vitamin E Oil
According to a class action complaint filed in California’s Northern District, L’Oreal shortchanges consumers by packaging liquid makeup offerings so that users cannot access significant amounts of product. Meanwhile, the authenticity of GNC’s Vitamin E Skin Oil is being challenged in another California federal court, and Unilever ducks a class action in Texas concerning mercury in Pond’s Rejuveness.
Low-skilled malicious hackers with physical access to certain Becton Dickinson hospital drug dispensers could access sensitive patient data and even alter them, a report from the US Department of Homeland Security says. The company and DHS are advising users to put extra measures in place to mitigate the threat while BD develops a software patch.